SCM Pharma is expanding its vial filling capabilities to support several clinical trials and commercial supply contracts. The company has invested more than £500k in new vial filling equipment for a dedicated suite at its facility. A new automated filler will allow for increased capacity and will integrate with the company’s containment isolator. The investment is geared towards companies requiring products for clinical trials and the supply of licensed drugs in niche markets, such as orphan drugs.
 
Neal Wesley, technical director at SCM Pharma, said, “The new kit will give us a true containment system for vial filling in that it will allow us to fill various types of potent materials in different sized vials while being totally safe for the product and operator. By having a system that isn’t compromised in anyway, we are able to handle more cytotoxic products such as oncology drugs, which we can safely fill at speed into vials under aseptic conditions to meet the demands of our clients.”